Nicotine transdermal system step 2 NDC 63868-734

Product information

Brand name (proprietary)

Nicotine transdermal system step 2Suffix: transdermal system step 2

Generic name (nonproprietary)

nicotine

Active ingredients

Nicotine — 14 mg/24h

Dosage form

Patch, Extended release

Route

Transdermal

Labeler

Chain Drug Marketing Association INC

Product type

Over-the-counter drug

Marketing category

NDA — New Drug ApplicationApplication NDA 020076

Marketing start

Oct 31, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Nicotine (Chemical structure)

Identifiers

Product ID 63868-734_883afa1b-0596-db0f-b029-26d3d6a7d110SPL ID 883afa1b-0596-db0f-b029-26d3d6a7d110SPL set ID df1348cb-0d15-7e4b-921c-d8764c858e66RxCUI 198029, 198030UNII 6M3C89ZY6R

Pharmacologic class

Cholinergic Nicotinic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463868073414 followed by a unit qualifier and the quantity Copy

Package 63868-0734-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 020076

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.